M. Dunn
Impact in
- Immunology top 5%
- Psoriasis: Treatment and Pathogenesis
- IL-33, ST2, and ILC Pathways
- Dermatology top 2%
- Dermatology and Skin Diseases
Papers in
-
- Psoriasis: Treatment and Pathogenesis 4
-
- Dermatology and Skin Diseases 2
- Co-authors
- Angelika JahreisAlice B. GottliebStephen K. TyringKenneth B. GordonYves PoulinRichard G. LangleyRaymond A. SobelHoward N. Hodis
- Journals
- Controlled Clinical Trials (1 paper)American Journal of Respiratory and Critical Care Medicine (1 paper)Journal of Allergy and Clinical Immunology (1 paper)Lara D. Veeken (1 paper)Archives of Gerontology and Geriatrics (1 paper)
- Partner nations
- United StatesCanada
In The Last Decade
M. Dunn
14 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 96
- Immunology 615
- Dermatology 237
- Rheumatology 320
- Hematology 190
- Biophysics 77
Countries citing papers authored by M. Dunn
This map shows the geographic impact of M. Dunn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Dunn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Dunn more than expected).
Fields of papers citing papers by M. Dunn
This network shows the impact of papers produced by M. Dunn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Dunn. The network helps show where M. Dunn may publish in the future.
Co-authors
The 25 scholars most cited alongside M. Dunn, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 228 | |
| 2 | 2010 | 43 | |
| 3 | Long-term safety and efficacy of etanercept in patients with psoriasis: an open-label study. | 2010 | 66 |
| 4 | 2009 | 3 | |
| 5 | 2007 | 268 | |
| 6 | 2007 | 52 | |
| 7 | 2006 | 31 | |
| 8 | Continued inhibition of radiographic progression in patients with psoriatic arthritis following 2 years of treatment with etanercept. | 2006 | 167 |
| 9 | 1997 | 10 | |
| 10 | 1997 | 12 | |
| 11 | 1997 | 140 | |
| 12 | 1996 | 110 | |
| 13 | 1995 | 9 | |
| 14 | 1993 | 67 |
About M. Dunn
M. Dunn is a scholar working on Immunology, Dermatology, Rheumatology, Physiology and Hematology, having authored 14 papers that have together received 1.2k indexed citations. Recurring topics across this work include Psoriasis: Treatment and Pathogenesis (4 papers), Asthma and respiratory diseases (4 papers), Rheumatoid Arthritis Research and Therapies (3 papers), Dermatology and Skin Diseases (2 papers), Dementia and Cognitive Impairment Research (2 papers), Spondyloarthritis Studies and Treatments (2 papers), Lipoproteins and Cardiovascular Health (2 papers) and Autoimmune and Inflammatory Disorders Research (2 papers). The work is most often cited by research in Immunology (615 citations), Dermatology (237 citations), Rheumatology (320 citations), Hematology (190 citations) and Biophysics (77 citations). M. Dunn has collaborated with scholars based in United States and Canada. Frequent co-authors include Angelika Jahreis, Alice B. Gottlieb, Stephen K. Tyring, Kenneth B. Gordon, Yves Poulin, Richard G. Langley, Raymond A. Sobel, Howard N. Hodis, Wendy J. Mack and Philip J. Mease. Their work appears in journals such as Controlled Clinical Trials, American Journal of Respiratory and Critical Care Medicine, Journal of Allergy and Clinical Immunology, Lara D. Veeken and Archives of Gerontology and Geriatrics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.